Join
Live feed
·
INSIDERFilingvia Quantisnow
bluebird bio Inc. logo

President and CEO Obenshain Andrew was granted 130,000 shares and sold $18,270 worth of shares (34,780 units at $0.53), increasing direct ownership by 34% to 375,218 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BLUE· bluebird bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLUE (bluebird bio Inc.) and more on Quantisnow.